07:00 , Aug 29, 2013 |  BC Innovations  |  Cover Story

Sleuthing for toxicity

Immunocore Ltd. , Adaptimmune Ltd. and University of Pennsylvania researchers have determined that off-target toxicity most likely caused the two fatalities in a cancer trial of affinity-enhanced T cell receptor s. 1 The results highlight...